Assembly Biosciences, Inc

ASMBNASDAQ • USD
21.30 USD
↗ 0.17 (0.81%)🔴AT CLOSE (AS OF 04:14 PM EST)
🔴Market: CLOSED

ASMB is currently priced at $21.30. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. ASMB is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$21.12
High?$21.81
Low?$21.00
Prev. Close?$21.12
Volume?514.3K
Avg. Volume?241.8K
VWAP?$21.40
Rel. Volume?2.13x
Bid / Ask
Bid?$19.54 × 100
Ask?$23.90 × 100
Spread?$4.36
Midpoint?$21.72
Valuation & Ratios
Market Cap?432.5M
Shares Out?20.4M
Float?10.4M
Float %?65.5%
P/E Ratio?N/A
P/B Ratio?1.45
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Employees
73
Market Cap
432.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2010-12-17
Address
TWO TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
Phone: (833) 409-4583
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
50
Short Sent.?
10
Piotroski F-Score?2/9Weak
Altman Z-Score?7.15Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?29.16%Squeeze Risk
Short Interest?3.0M
Days to Cover?17.0
Free Float10.4M
Avg Daily Volume178.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?12.89Strong
Quick Ratio?12.89Strong
Cash Ratio?1.17Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
88
1.45CHEAP▾
P/S?
Peers
100
S&P
19
6.45FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-19.0CHEAP▾
EV/Sales?
Peers
100
S&P
28
6.02HIGH▾
Returns & Efficiency
ROE?
S&P
12
-3.7%WEAK▾
ROA?
S&P
3
-3.4%WEAK▾
Cash Flow & Enterprise
FCF?$-40676000
Enterprise Value?$403.4M
Fundamentals ratios updated end of day